The Significance of Postoperative Muscle Wasting in Pancreatic Cancer
National Cheng Kung University Hospital
1 other identifier
observational
208
1 country
1
Brief Summary
To assess the impact of preoperative sarcopenia and postoperative skeletal muscle wasting on the outcomes of patients with resectable pancreatic cancer who underwent pancreatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2002
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 16, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedOctober 24, 2023
October 1, 2023
17.8 years
October 16, 2023
October 22, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Overall survival
Overall survival was measured as the period between the date of resection and the date of the last follow-up or death.
10 years
Disease-free survival
Disease-free survival was defined as the duration from resection to cancer relapse (local, peritoneal recurrence, or distal metastasis).
10 years
Interventions
Eligibility Criteria
20 Years and older (Adult, Older Adult ).
You may qualify if:
- Clinical diagnosis of pancreatic cancer
- Must be able to undergo pancreatectomy
- Must be able to undergo pre- and post-operative abdominal computed tomography scan
You may not qualify if:
- Unresectable pancreatic cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cheng Kung University Hospital
Tainan, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2023
First Posted
October 23, 2023
Study Start
June 1, 2002
Primary Completion
April 1, 2020
Study Completion
June 1, 2023
Last Updated
October 24, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share
The datasets generated and/or analyzed during the current study are not publicly available due to privacy issues.